Endogenous Positive Allosteric Modulation of GABAA Receptors by Diazepam binding inhibitor

Neuron

Volumn 78, Issue 6, 2013, Pages 1063-1074

  Christian, CatherineA ^a   Herbert, AnneG ^a   Holt, RebeccaL ^a   Peng, Kathy ^a   Sherwood, KylaD ^a   Pangratz Fuehrer, Susanne ^a   Rudolph, Uwe ^b   Huguenard, JohnR ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MCLEAN HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; BENZODIAZEPINE; DIAZEPAM BINDING INHIBITOR; FLUMAZENIL;

ALLOSTERISM; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BINDING SITE; CONTROLLED STUDY; DIAZEPAM BINDING INHIBITOR GENE; GABAERGIC TRANSMISSION; GENE DELETION; GENE FUNCTION; GENE MUTATION; GENE PRODUCT; INHIBITORY POSTSYNAPTIC POTENTIAL; NERVE CONDUCTION; NONHUMAN; OSCILLATION; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; SIGNAL TRANSDUCTION; SPIKE WAVE; THALAMUS RETICULAR NUCLEUS; VIRAL GENE DELIVERY SYSTEM;

ALLOSTERIC REGULATION; AMINO ACID SUBSTITUTION; ANIMALS; BENZODIAZEPINES; DIAZEPAM BINDING INHIBITOR; FEMALE; GAMMA-AMINOBUTYRIC ACID; INHIBITORY POSTSYNAPTIC POTENTIALS; MALE; MICE; MICE, 129 STRAIN; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; MUTATION; NEURAL INHIBITION; RECEPTORS, GABA-A; THALAMUS;

EID: 84879252425     PISSN: 08966273     EISSN: 10974199     Source Type: Journal    
DOI: 10.1016/j.neuron.2013.04.026     Document Type: Article

References (87)

1. Alfonso J., Le Magueresse C., Zuccotti A., Khodosevich K., Monyer H. Diazepam binding inhibitor promotes progenitor proliferation in the postnatal SVZ by reducing GABA signaling. Cell Stem Cell 2012, 10:76-87.
2. Alho H., Costa E., Ferrero P., Fujimoto M., Cosenza-Murphy D., Guidotti A. Diazepam-binding inhibitor: a neuropeptide located in selected neuronal populations of rat brain. Science 1985, 229:179-182.
3. Alho H., Bovolin P., Jenkins D., Guidotti A., Costa E. Cellular and subcellular localization of an octadecaneuropeptide derived from diazepam binding inhibitor: immunohistochemical studies in the rat brain. J.Chem. Neuroanat. 1989, 2:301-318.
4. Allen T.G.J. The 'sniffer-patch' technique for detection of neurotransmitter release. Trends Neurosci. 1997, 20:192-197.
5. Banks M.I., Pearce R.A. Kinetic differences between synaptic and extrasynaptic GABA(A) receptors in CA1 pyramidal cells. J.Neurosci. 2000, 20:937-948.
6. Beenhakker M.P., Huguenard J.R. Neurons that fire together also conspire together: is normal sleep circuitry hijacked to generate epilepsy?. Neuron 2009, 62:612-632.
7. Beenhakker M.P., Huguenard J.R. Astrocytes as gatekeepers of GABAB receptor function. J.Neurosci. 2010, 30:15262-15276.
8. Bormann J., Ferrero P., Guidotti A., Costa E. Neuropeptide modulation of GABA receptor C1- channels. Regul. Pept. Suppl. 1985, 4:33-38.
9. Bowser D.N., Wagner D.A., Czajkowski C., Cromer B.A., Parker M.W., Wallace R.H., Harkin L.A., Mulley J.C., Marini C., Berkovic S.F., et al. Altered kinetics and benzodiazepine sensitivity of a GABAA receptor subunit mutation [gamma 2(R43Q)] found in human epilepsy. Proc. Natl. Acad. Sci. USA 2002, 99:15170-15175.
10. Braestrup C., Squires R.F. Specific benzodiazepine receptors in rat brain characterized by high-affinity (3H)diazepam binding. Proc. Natl. Acad. Sci. USA 1977, 74:3805-3809.
11. Conigrave A.D., Franks A.H. Allosteric activation of plasma membrane receptors-physiological implications and structural origins. Prog. Biophys. Mol. Biol. 2003, 81:219-240.
12. Cox C.L., Huguenard J.R., Prince D.A. Heterogeneous axonal arborizations of rat thalamic reticular neurons in the ventrobasal nucleus. J.Comp. Neurol. 1996, 366:416-430.
13. Crunelli V., Leresche N. Childhood absence epilepsy: genes, channels, neurons and networks. Nat. Rev. Neurosci. 2002, 3:371-382.
14. De Deyn P.P., Macdonald R.L. CGS 9896 and ZK 91296, but not CGS 8216 and RO 15-1788, are pure benzodiazepine receptor antagonists on mouse neurons in culture. J.Pharmacol. Exp. Ther. 1987, 242:48-55.
15. De Koninck Y., Mody I. Noise analysis of miniature IPSCs in adult rat brain slices: properties and modulation of synaptic GABAA receptor channels. J.Neurophysiol. 1994, 71:1318-1335.
16. De Mateos-Verchere J.G., Leprince J., Tonon M.C., Vaudry H., Costentin J. The octadecaneuropeptide ODN induces anxiety in rodents: possible involvement of a shorter biologically active fragment. Peptides 1998, 19:841-848.
17. Dong E., Matsumoto K., Tohda M., Watanabe H. Involvement of diazepam binding inhibitor and its fragment octadecaneuropeptide in social isolation stress-induced decrease in pentobarbital sleep in mice. Life Sci. 1999, 64:1779-1784.
18. Ferrero P., Santi M.R., Conti-Tronconi B., Costa E., Guidotti A. Study of an octadecaneuropeptide derived from diazepam binding inhibitor (DBI): biological activity and presence in rat brain. Proc. Natl. Acad. Sci. USA 1986, 83:827-831.
19. Fritschy J.M., Mohler H. GABAA-receptor heterogeneity in the adult rat brain: differential regional and cellular distribution of seven major subunits. J.Comp. Neurol. 1995, 359:154-194.
20. Galarreta M., Hestrin S. Properties of GABAA receptors underlying inhibitory synaptic currents in neocortical pyramidal neurons. J.Neurosci. 1997, 17:7220-7227.
21. Garcia de Mateos-Verchere J., Leprince J., Tonon M.C., Vaudry H., Costentin J. Reduction of pentylenetetrazol-induced convulsions by the octadecaneuropeptide ODN. Peptides 1999, 20:1431-1436.
22. Gavish M., Snyder S.H. Benzodiazepine recognition sites on GABA receptors. Nature 1980, 287:651-652.
23. Gibbs J.W., Schroder G.B., Coulter D.A. GABAA receptorfunction in developing rat thalamic reticular neurons: whole cell recordings of GABA-mediated currents and modulation by clonazepam. J.Neurophysiol. 1996, 76:2568-2579.
24. Guidotti A., Forchetti C.M., Corda M.G., Konkel D., Bennett C.D., Costa E. Isolation, characterization, and purification to homogeneity of an endogenous polypeptide with agonistic action on benzodiazepine receptors. Proc. Natl. Acad. Sci. USA 1983, 80:3531-3535.
25. Hadingham K.L., Garrett E.M., Wafford K.A., Bain C., Heavens R.P., Sirinathsinghji D.J., Whiting P.J. Cloning of cDNAs encoding the human gamma-aminobutyric acid type A receptor alpha 6 subunit and characterization of the pharmacology of alpha 6-containing receptors. Mol. Pharmacol. 1996, 49:253-259.
26. Hentschke H., Benkwitz C., Banks M.I., Perkins M.G., Homanics G.E., Pearce R.A. Altered GABAA,slow inhibition and network oscillations in mice lacking the GABAA receptor beta3 subunit. J.Neurophysiol. 2009, 102:3643-3655.
27. Hosford D.A., Clark S., Cao Z., Wilson W.A.J., Lin F.H., Morrisett R.A., Huin A. The role of GABAB receptor activation in absence seizures of lethargic (lh/lh) mice. Science 1992, 257:398-401.
28. Huguenard J.R. Neuronal circuitry of thalamocortical epilepsy and mechanisms of antiabsence drug action. Adv. Neurol. 1999, 79:991-999.
29. Huguenard J.R., Prince D.A. Clonazepam suppresses GABAB-mediated inhibition in thalamic relay neurons through effects in nucleus reticularis. J.Neurophysiol. 1994, 71:2576-2581.
30. Huguenard J.R., Prince D.A. Intrathalamic rhythmicity studied invitro: nominal T-current modulation causes robust antioscillatory effects. J.Neurosci. 1994, 14:5485-5502.
31. Hunkeler W., Möhler H., Pieri L., Polc P., Bonetti E.P., Cumin R., Schaffner R., Haefely W. Selective antagonists of benzodiazepines. Nature 1981, 290:514-516.
32. Huntsman M.M., Huguenard J.R. Nucleus-specific differences in GABA(A)-receptor-mediated inhibition are enhanced during thalamic development. J.Neurophysiol. 2000, 83:350-358.
33. Huntsman M.M., Huguenard J.R. Fast IPSCs in rat thalamic reticular nucleus require the GABAA receptor beta1 subunit. J.Physiol. 2006, 572:459-475.
34. Huntsman M.M., Porcello D.M., Homanics G.E., DeLorey T.M., Huguenard J.R. Reciprocal inhibitory connections and network synchrony in the mammalian thalamus. Science 1999, 283:541-543.
35. Isaacson J.S., Solís J.M., Nicoll R.A. Local and diffuse synaptic actions of GABA in the hippocampus. Neuron 1993, 10:165-175.
36. Iversen L. Anti-anxiety receptors in the brain?. Nature 1977, 266:678.
37. Jones M.V., Westbrook G.L. Shaping of IPSCs by endogenous calcineurin activity. J.Neurosci. 1997, 17:7626-7633.
38. Kang J.Q., Macdonald R.L. The GABAA receptor gamma2 subunit R43Q mutation linked to childhood absence epilepsy and febrile seizures causes retention of alpha1beta2gamma2S receptors in the endoplasmic reticulum. J.Neurosci. 2004, 24:8672-8677.
39. Kavaliers M., Hirst M. An octadecaneuropeptide (ODN) derived from diazepam binding inhibitor increases aggressive interactions in mice. Brain Res. 1986, 383:343-349.
40. King G.L., Knox J.J., Dingledine R. Reduction of inhibition by a benzodiazepine antagonist, Ro15-1788, in the rat hippocampal slice. Neuroscience 1985, 15:371-378.
41. Knoflach F., Benke D., Wang Y., Scheurer L., Lüddens H., Hamilton B.J., Carter D.B., Mohler H., Benson J.A. Pharmacological modulation of the diazepam-insensitive recombinant gamma-aminobutyric acidA receptors alpha 4 beta 2 gamma 2 and alpha 6 beta 2 gamma 2. Mol. Pharmacol. 1996, 50:1253-1261.
42. Knudsen J. Acyl-CoA-binding and transport, an alternative function for diazepam binding inhibitor (DBI), which is identical with acyl-CoA-binding protein. Neuropharmacology 1991, 30(12B):1405-1410.
43. Knudsen J., Mandrup S., Rasmussen J.T., Andreasen P.H., Poulsen F., Kristiansen K. The function of acyl-CoA-binding protein (ACBP)/diazepam binding inhibitor (DBI). Mol. Cell. Biochem. 1993, 123:129-138.
44. Lee L., DeBono C.A., Campagna D.R., Young D.C., Moody D.B., Fleming M.D. Loss of the acyl-CoA binding protein (Acbp) results in fatty acid metabolism abnormalities in mouse hair and skin. J.Invest. Dermatol. 2007, 127:16-23.
45. Lein E.S., Hawrylycz M.J., Ao N., Ayres M., Bensinger A., Bernard A., Boe A.F., Boguski M.S., Brockway K.S., Byrnes E.J., et al. Genome-wide atlas of gene expression in the adult mouse brain. Nature 2007, 445:168-176.
46. Leprince J., Gandolfo P., Thoumas J.L., Patte C., Fauchère J.L., Vaudry H., Tonon M.C. Structure-activity relationships of a series of analogues of the octadecaneuropeptide ODN on calcium mobilization in rat astrocytes. J.Med. Chem. 1998, 41:4433-4438.
47. Lihrmann I., Plaquevent J.C., Tostivint H., Raijmakers R., Tonon M.C., Conlon J.M., Vaudry H. Frog diazepam-binding inhibitor: peptide sequence, cDNA cloning, and expression in the brain. Proc. Natl. Acad. Sci. USA 1994, 91:6899-6903.
48. Llinás R., Jahnsen H. Electrophysiology of mammalian thalamic neurones invitro. Nature 1982, 297:406-408.
49. Löw K., Crestani F., Keist R., Benke D., Brünig I., Benson J.A., Fritschy J.M., Rülicke T., Bluethmann H., Möhler H., Rudolph U. Molecular and neuronal substrate for the selective attenuation of anxiety. Science 2000, 290:131-134.
50. Macdonald R.L., Weddle M.G., Gross R.A. Benzodiazepine, beta-carboline, and barbiturate actions on GABA responses. Adv. Biochem. Psychopharmacol. 1986, 41:67-78.
51. Mody I., De Koninck Y., Otis T.S., Soltesz I. Bridging the cleft at GABA synapses in the brain. Trends Neurosci. 1994, 17:517-525.
52. Möhler H., Okada T. Benzodiazepine receptor: demonstration in the central nervous system. Science 1977, 198:849-851.
53. Mozrzymas J.W., Barberis A., Vicini S. GABAergic currents in RT and VB thalamic nuclei follow kinetic pattern of alpha3- and alpha1-subunit-containing GABAA receptors. Eur. J. Neurosci. 2007, 26:657-665.
54. Noebels J.L., Sidman R.L. Inherited epilepsy: spike-wave and focal motor seizures in the mutant mouse tottering. Science 1979, 204:1334-1336.
55. Oh K.S., Lee C.J., Gibbs J.W., Coulter D.A. Postnatal development of GABAA receptor function in somatosensory thalamus and cortex: whole-cell voltage-clamp recordings in acutely isolated rat neurons. J.Neurosci. 1995, 15:1341-1351.
56. Ohgami R.S., Campagna D.R., Greer E.L., Antiochos B., McDonald A., Chen J., Sharp J.J., Fujiwara Y., Barker J.E., Fleming M.D. Identification of a ferrireductase required for efficient transferrin-dependent iron uptake in erythroid cells. Nat. Genet. 2005, 37:1264-1269.
57. Papadopoulos V., Berkovich A., Krueger K.E., Costa E., Guidotti A. Diazepam binding inhibitor and its processing products stimulate mitochondrial steroid biosynthesis via an interaction with mitochondrial benzodiazepine receptors. Endocrinology 1991, 129:1481-1488.
58. Peden D.R., Petitjean C.M., Herd M.B., Durakoglugil M.S., Rosahl T.W., Wafford K., Homanics G.E., Belelli D., Fritschy J.M., Lambert J.J. Developmental maturation of synaptic and extrasynaptic GABAA receptors in mouse thalamic ventrobasal neurones. J.Physiol. 2008, 586:965-987.
59. Pinault D., Smith Y., Deschênes M. Dendrodendritic and axoaxonic synapses in the thalamic reticular nucleus of the adult rat. J.Neurosci. 1997, 17:3215-3233.
60. Pirker S., Schwarzer C., Wieselthaler A., Sieghart W., Sperk G. GABA(A) receptors: immunocytochemical distribution of 13 subunits in the adult rat brain. Neuroscience 2000, 101:815-850.
61. Ramerstorfer J., Furtmüller R., Vogel E., Huck S., Sieghart W. The point mutation gamma 2F77I changes the potency and efficacy of benzodiazepine site ligands in different GABAA receptor subtypes. Eur. J. Pharmacol. 2010, 636:18-27.
62. Rudolph U., Möhler H. Analysis of GABAA receptor function and dissection of the pharmacology of benzodiazepines and general anesthetics through mouse genetics. Annu. Rev. Pharmacol. Toxicol. 2004, 44:475-498.
63. Rudolph U., Crestani F., Benke D., Brünig I., Benson J.A., Fritschy J.M., Martin J.R., Bluethmann H., Möhler H. Benzodiazepine actions mediated by specific gamma-aminobutyric acid(A) receptor subtypes. Nature 1999, 401:796-800.
64. Ryan L.J., Sharpless S.K. Genetically determined spontaneous and pentylenetetrazol-induced brief spindle episodes in mice. Exp. Neurol. 1979, 66:493-508.
65. Rye D.B., Bliwise D.L., Parker K., Trotti L.M., Saini P., Fairley J., Freeman A., Garcia P.S., Owens M.J., Ritchie J.C., et al. Modulation of vigilance in the primary hypersomnias by endogenous enhancement of GABAA receptors. Sci. Transl. Med. 2012, 4. 161ra151.
66. Schofield C.M., Huguenard J.R. GABA affinity shapes IPSCs in thalamic nuclei. J.Neurosci. 2007, 27:7954-7962.
67. Schofield C.M., Kleiman-Weiner M., Rudolph U., Huguenard J.R. A gain in GABAA receptor synaptic strength in thalamus reduces oscillatory activity and absence seizures. Proc. Natl. Acad. Sci. USA 2009, 106:7630-7635.
68. Schwartz T.W., Holst B. Allosteric enhancers, allosteric agonists and ago-allosteric modulators: where do they bind and how do they act?. Trends Pharmacol. Sci. 2007, 28:366-373.
69. Shu Y., McCormick D.A. Inhibitory interactions between ferret thalamic reticular neurons. J.Neurophysiol. 2002, 87:2571-2576.
70. Sieghart W. Structure and pharmacology of gamma-aminobutyric acidA receptor subtypes. Pharmacol. Rev. 1995, 47:181-234.
71. Sigworth F.J. The variance of sodium current fluctuations at the node of Ranvier. J.Physiol. 1980, 307:97-129.
72. Skerritt J.H., Macdonald R.L. Benzodiazepine Ro 15-1788: electrophysiological evidence for partial agonist activity. Neurosci. Lett. 1983, 43:321-326.
73. Slobodyansky E., Kurriger G., Kultas-Ilinsky K. Diazepam binding inhibitor processing in the rhesus monkey brain: an immunocytochemical study. J.Chem. Neuroanat. 1992, 5:169-180.
74. Snead O.C. Ganaxolone, a selective, high-affinity steroid modulator of the gamma-aminobutyric acid-A receptor, exacerbates seizures in animal models of absence. Ann. Neurol. 1998, 44:688-691.
75. Sohal V.S., Huguenard J.R. Inhibitory interconnections control burst pattern and emergent network synchrony in reticular thalamus. J.Neurosci. 2003, 23:8978-8988.
76. Sohal V.S., Keist R., Rudolph U., Huguenard J.R. Dynamic GABA(A) receptor subtype-specific modulation of the synchrony and duration of thalamic oscillations. J.Neurosci. 2003, 23:3649-3657.
77. Steriade M., McCormick D.A., Sejnowski T.J. Thalamocortical oscillations in the sleeping and aroused brain. Science 1993, 262:679-685.
78. Tokuda K., O'Dell K.A., Izumi Y., Zorumski C.F. Midazolam inhibits hippocampal long-term potentiation and learning through dual central and peripheral benzodiazepine receptor activation and neurosteroidogenesis. J.Neurosci. 2010, 30:16788-16795.
79. Tonon M.C., Désy L., Nicolas P., Vaudry H., Pelletier G. Immunocytochemical localization of the endogenous benzodiazepine ligand octadecaneuropeptide (ODN) in the rat brain. Neuropeptides 1990, 15:17-24.
80. Vicini S., Alho H., Costa E., Mienville J.M., Santi M.R., Vaccarino F.M. Modulation of gamma-aminobutyric acid-mediated inhibitory synaptic currents in dissociated cortical cell cultures. Proc. Natl. Acad. Sci. USA 1986, 83:9269-9273.
81. von Krosigk M., Bal T., McCormick D.A. Cellular mechanisms of a synchronized oscillation in the thalamus. Science 1993, 261:361-364.
82. Wallace R.H., Marini C., Petrou S., Harkin L.A., Bowser D.N., Panchal R.G., Williams D.A., Sutherland G.R., Mulley J.C., Scheffer I.E., Berkovic S.F. Mutant GABA(A) receptor gamma2-subunit in childhood absence epilepsy and febrile seizures. Nat. Genet. 2001, 28:49-52.
83. Weiss M., Tikhonov D., Buldakova S. Effect of flumazenil on GABAA receptors in isolated rat hippocampal neurons. Neurochem. Res. 2002, 27:1605-1612.
84. Whittemore E.R., Yang W., Drewe J.A., Woodward R.M. Pharmacology of the human gamma-aminobutyric acidA receptor alpha 4 subunit expressed in Xenopus laevis oocytes. Mol. Pharmacol. 1996, 50:1364-1375.
85. Wisden W., Laurie D.J., Monyer H., Seeburg P.H. The distribution of 13 GABAA receptor subunit mRNAs in the rat brain. I. Telencephalon, diencephalon, mesencephalon. J.Neurosci. 1992, 12:1040-1062.
86. Yung W.H., Leung P.S., Ng S.S., Zhang J., Chan S.C., Chow B.K. Secretin facilitates GABA transmission in the cerebellum. J.Neurosci. 2001, 21:7063-7068.
87. Zhang S.J., Huguenard J.R., Prince D.A. GABAA receptor-mediated Cl- currents in rat thalamic reticular and relay neurons. J.Neurophysiol. 1997, 78:2280-2286.